Cognitive Rehabilitation for Long COVID Brain Fog
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist people with long COVID who experience persistent brain fog and mild to moderate cognitive issues. Researchers will compare two types of cognitive rehabilitation: Processing Speed Training, which focuses on improving processing speed and work-related tasks, and Reaction Time Training, which enhances reaction time and healthy lifestyle habits. Both approaches include non-invasive vagus nerve stimulation, a procedure that might improve cognitive function. People who have faced brain fog and cognitive challenges for at least three months after COVID and struggle with daily activities might be suitable candidates. Participants can also receive vocational rehabilitation if they need help returning to work. As an unphased trial, this study offers an opportunity to explore innovative cognitive rehabilitation methods that could enhance daily functioning.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both treatments under study, Constraint-Induced Cognitive Therapy (CICT) and Brain Fitness Training (BFT), are considered safe so far. Earlier studies have used CICT with stroke survivors, and it is well-tolerated by individuals with mild-to-moderate cognitive issues. Although specific side effects weren't detailed, the absence of reported problems suggests general safety.
For Brain Fitness Training, the research focuses on exercises that improve habits and thinking skills. Studies have shown that similar brain-training exercises for long COVID symptoms have been used without major safety concerns, indicating typical safety.
Both treatments in this study include trans-auricular vagus nerve stimulation (taVNS). Research indicates that taVNS is generally safe and well-tolerated, with mostly mild and short-lived side effects. This non-invasive method has been used for various conditions, enhancing its safety record.
Overall, the treatments have demonstrated a promising safety record. Participants considering joining the trial are likely to find the interventions well-tolerated based on available evidence.12345Why are researchers excited about this trial?
Researchers are excited about these cognitive rehabilitation methods for Long COVID brain fog because they combine innovative techniques like processing speed and reaction time training with non-invasive vagus nerve stimulation. Unlike traditional treatments that might focus solely on therapy or medication, these approaches integrate cognitive exercises with lifestyle changes, such as vocational rehabilitation and healthy living practices. This comprehensive strategy aims to enhance everyday cognitive functions and promote lasting improvements, offering a fresh and potentially more holistic solution for those struggling with persistent cognitive issues post-COVID.
What evidence suggests that this trial's treatments could be effective for long COVID brain fog?
Research has shown that Constraint-Induced Cognitive Therapy (CICT), one of the treatments tested in this trial, can improve symptoms of long COVID, such as brain fog. Studies have found that people who tried CICT experienced a significant reduction in brain fog and tiredness. In another study, participants noticed significant improvements in their thinking skills and ability to work.
Brain Fitness Training (BFT), another treatment option in this trial, also shows promise. A review found that many participants experienced less brain fog and fatigue, suggesting that BFT could help manage these long COVID symptoms.
Additionally, trans-auricular Vagus Nerve Stimulation (taVNS), included in the various treatment arms of this trial, has improved long COVID symptoms, including cognitive issues. Studies indicate that taVNS can be a safe and effective way to ease symptoms like brain fog.12678Who Is on the Research Team?
Gitendra Uswatte, PhD
Principal Investigator
Professor of Psychology, University of Alabama at Birmingham
Are You a Good Fit for This Trial?
Adults with long COVID experiencing mild to moderate cognitive issues, such as brain fog and trouble with daily activities. They must be over 3 months post-COVID, able to travel to the lab, mentally and physically fit enough for participation, have good vision and hearing, follow instructions well, and speak English. Excluded are those with a history of stroke before COVID-19 or current substance abuse.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 30 hours of training over 2 to 4 weeks, including web-based games, in-lab training, and vagus nerve stimulation
Follow-up
Participants receive four follow-up phone calls to promote integration of skills gained during training into everyday life
Long-term Follow-up
Participants are monitored for cognitive processing speed and performance in everyday activities at 6 and 12 months post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Processing Speed Training
- Reaction Time Training
- Trans-auricular Vagus Nerve Stimulation: High Intensity
- Trans-auricular Vagus Nerve Stimulation: Low Intensity
Processing Speed Training is already approved in United States, Canada for the following indications:
- Cognitive impairment in older adults
- Long COVID brain fog
- Cognitive impairment in older adults
- Long COVID brain fog
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Posit Science
Collaborator
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator